Review: Immunobiology of preeclampsia

American Journal of Reproductive Immunology

Volumn 37, Issue 1, 1997, Pages 79-86

  Taylor, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigens; Preeclampsia; Primigravidae

Indexed keywords

COMPLEMENT; CYTOKINE; FETAL ANTIGEN; FIBRIN; PHOSPHOLIPID ANTIBODY;

ARTICLE; BLOOD TRANSFUSION; CELLULAR IMMUNITY; COLLAGEN DISEASE; COMPLEMENT DEPOSITION; CONDOM; CONTRACEPTION; EDEMA; ENDOTHELIUM CELL; FOAM CELL; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; HYDATIDIFORM MOLE; HYPERTENSION; IMMUNOBIOLOGY; IMMUNOGENETICS; KIDNEY ALLOGRAFT REJECTION; LEUKOCYTE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PREVALENCE; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEINURIA; RISK; T LYMPHOCYTE ACTIVATION; VASCULAR DISEASE; VASOSPASM;

EID: 0031038768     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00195.x     Document Type: Article

References (99)

1. Roberts JM, Redman CW. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341:1447-1451.
2. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study: The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172:642-648.
3. Eastman NJ. The toxemias of pregnancy. In: Williams obstetrics, l0thEd. Appleton-Century-Crofts, New York, 1950.
4. Burrows RF, Burrows EA. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995; 173:929-935.
5. Houser MT, Fish AJ, Tagatz GE, et al. pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol 1980; 138:409-413.
6. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
7. Kitzmiller JL, Benirschke K. Immunofluorescent study of placental bed vessels in preeclampsia of pregnancy. Am J Obstet Gynecol 1973; 115:248-251.
8. Dieckmann WJ. The toxemias of pregnancy. In: Factors influencing eclampsia in pregnant women. CV Mosby, St. Louis, 1941:250-251.
9. Robillard PY, Hulsey TC, Alexander GR, et al. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 1993; 24:1-12.
10. Klonoff-Cohen, H.S., Savitz DA, Cefalo RC, et al. An epidemiologic study of contraception and preeclampsia. JAMA 1989; 262:3143-3147.
11. Feeney JG, Tovey LA, Scott JS. Influence of previous blood-transfusion on incidence of pre-eclampsia. Lancet 1977; 1:874-875.
12. Dekker GA. Oral tolerization to paternal antigens and preeclampsia. Am J Obstet Gynecol 1996; 174:450.
13. Robillard PY, Hulsey TC, Perianin J, et al. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344:973-975.
14. Feinberg BB, Gonik B. General precepts of the immunology of pregnancy. Clin Obstet Gynecol 1991; 34:3-16.
15. Matthiesen L, Berg G, Ernerudh, et al. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol 1995; 33:31-39.
16. Toder V, Blank M, Gleicher N, et al. Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis. Am J Obstet Gynecol 1983; 145:7-10.
17. Greer IA, Dawes J, Johnson TA, et al. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 1991; 78:28-32.
18. Billington WD. Maternal immune response to pregnancy. Reprod Fertil Dev 1989; 1:183-191.
19. Bulmer JN, Longfellow M. Leukocytes and resident blood cells in endometrium. Ann NY Acad Sci 1991; 622:57-68.
20. Stites DP, Pavia CS, Clemens LE, et al. Immunologic regulation in pregnancy. Arthritis Rheumatol 1979; 22:1300-1307.
21. Colbern GT, Main EK. Immunology of the maternal-placental interface in normal pregnancy. Semin Perinatol 1991; 15:196-205.
22. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248:220-223.
23. McMaster MT, Librach CL, Zhou Y, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995; 154:3771-3778.
24. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: An endothelial cell disorder Am J Obstet Gynecol 1989; 161:1200-1204.
25. Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049-1059.
26. Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98:648-655.
27. Fisher SJ, Damsky CH. Human cytotrophoblast invasion. Semin Cell Biol 1993; 4:183-188.
28. de Groot CJM, O'Brien TJ, Taylor RN. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J Obstet Gynecol 175:24-29, 1996.
29. Bower S, Schuchter K, Campbell S. Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1993; 100:989-994.
30. Fitzgerald DJ, Entman SS, Mulloy K, et al. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75:956-963.
31. Remuzzi G, Marchesi D, Zoja C, et al. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 1980; 20:105-110.
32. Taylor RN, Varma M, Teng NNH, et al. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71:1675-1677.
33. Nova A, Sibai BM, Barton JR, et al. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991; 165:724-727.
34. Lockwood CJ, Peters JH. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990; 162:358-362.
35. Taylor RN, Crombleholme WR, Friedman SA, et al. High Plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension atone. Am J Obstet Gynecol 1991; 165(4):895-901.
36. Hsu CD, Iriye B, Johnson TR, et al. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1993; 169:148-149.
37. Kincaid-Smith P. Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Internat 1975; 7:242-253.
38. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. II. Mitochondrial changes. Am J Obstet Gynecol 163:943-953.
39. Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52:2682-2689.
40. McCarthy AL, Woolfson RG, Raju SK, et al. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993; 168:1323-1330.
41. Kahaleh MB. The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response. Clin Exp Rheumatol 1990; 8:595-601.
42. Arias F, Andrinopoulos G, Zamora J. Whole-blood fibrinolytic activity in normal and hypertensive pregnancies and its relation to placental concentration of urokinase inhibitor. Am J Obstet Gynecol 1979; 133:624-629.
43. Triplett DA. Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 1992; 28:211-215.
44. Cutolo M, Sulli A, Seriolo B, et al. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13:217-226.
45. Lim KH, Rice GE de Groot CMJ, et al. Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 1995; 172:998-1002.
46. Colbern GT, Chiang MH, Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994; 170:1244-1250.
47. Lim KH, Bass K, Chun SH, et al. Differentiation of invasive cytotrophoblasts in normal and abnormal pregnancy. Soc Gynecol Invest 1994; 42:107A.
48. Humphrey KE, Harrison GA, Cooper DW, et al. HLA-G deletion polymorphism and preeclampsia/eclampsia. Br J Obstet Gynaecol 1995; 102:707-710.
49. Giacomini P, Tosi S, Murgia C, et al. First-trimester human trophoblast is class II major histocompatibility complex mRNA+/antigen-. Hum Immunol 1994; 39:281-289.
50. Labarrere CA, Faulk WP. Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens are expressed on endovascular cytotrophoblasts in abnormal pregnancies. Am J Reprod Immunol 1995; 33:47-53.
51. Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159:908-914.
52. Tsukimori K, Maeda H, Shingu M, et al. The possible role of endothelial cell in hypertensive disorders during pregnancy. Obstet Gynecol 1992; 80:229-233.
53. Kupfermine MJ, Mullen TA, Russell TL, et al. Serum from patients with severe preeclampsia is not cytotoxic to endothelial cells. J Soc Gynecol Invest 1996; 3:89-92.
54. Endresen MJ, Tosti E, Lorentzen B, et al. Sera of preeclamptic women are not cytotoxic to endothelial cells in culture. Am J Obstet Gynecol 1995; 172:196-201.
55. Roberts JM, Edep ME, Goldfein A, et al. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol 1992; 27:101-108.
56. Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993; 119:819-827.
57. Stricker RB, Main EK, Kronfield J, et al. Severe post-partum eclampsia: response to plasma exchange. J Clin Apheres 1992; 7:1-3.
58. Rappaport VJ, Hirata G, Yap HK, et al. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 1990; 162:138-146.
59. Branch DW. Antiphospholipid antibodies and pregnancy: Maternal implications. Semin Perinatol 1990; 14:139-146.
60. Rote NS, Walter A, Lyden TW. Antiphospholipid antibodies-lobsters or red herrings? Am J Reprod Immunol 1992; 28:31-37.
61. Yasuda M, Takakuwa K, Tokunaga A. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995; 86:555-559.
62. Carreras LO, Vermylen JG. "Lupus" anticoagulant and thrombosis: Possible role of inhibition of prostacyclin formation. Thrombos Haemostas 1982; 48:38-40.
63. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137:1532-1537.
64. Walker TS, Triplett DA, Javed N, et al. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. Thrombos Res 1988; 51:267-281.
65. de Groot CJ, Davidge S, Friedman S, et al. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass. Am J Obstet Gynecol 1995; 172.3:976-985.
66. Branch DW, Davidge ST, Friedman SA, et al. Sera from preeclamptic patients contain factor(s) that stimulate prostacyclin production by human endothelial cells. Prost Leuko Ess Fatty Acids 1992; 45:191-195.
67. Meekins JW, McLaughlin PJ, West DC, et al. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-ectampsia. Clin Exp Immunol 1994; 98:110-114.
68. Vince GS, Starkey PM, Austgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102:20-25.
69. Kupferminc MJ, Peaceman AM, Wigton TR, et al. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-1759.
70. Taylor RN, Musci TJ, Rodgers GM, et al. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human cells. Am J Reprod Immunol 1991; 25:105-108.
71. Taylor RN, Heilbron DC, Roberts JM. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol 1990; 163:1839-1844.
72. Bertani T, Abbate M, Zoja C, et al. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989; 134:419-430.
73. Jacobson PB, Schrier DJ. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2. J Immunol 1993; 151:5639-5652.
74. Pfeilschifter J, Schalkwijk C, Briner VA, et al. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 1993; 92:2516-2523.
75. Jendryczko A, Drózdz M. Increased placental phospholipase A2 activities in preeclampsia. Zentralbl Gynakol 1990; 112:889-891.
76. Opsjon SL, Novick D, Wathen NC, et al. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995; 29:119-134.
77. Domingo CG, Domenech N, Aparicio P, et al. Human pregnancy serum inhibits proliferation of T8-depleted cells and their interleukin-2 synthesis in mixed lymphocyte cultures. J Reprod Immunol 1985; 8:97-110.
78. Hara N, Fujii T, Okai T, et al. Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia. Am J Reprod Immunol 1995; 34:44-51.
79. Greer IA, Lyall F, Perera T, et al. Increased concentration of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? Obstet Gynecol 1994; 84:937-940.
80. Sudo N, Kamoi K, Ishibashi M, et al. Plasma endothelin-1 and big endothelin-1 levels in women with pre-eclampsia. Acta Endocrinol (Copenh) 1993; 129:114-120.
81. Benigni A, Orisio S, Gaspari F, et al. Evidence against a pathogenetic role for endothelin in pre-eclampsia. Br J Obstet Gynaecol 1992; 99:798-802.
82. McMahon LP, Redman CW, Firth JD. Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin Sci (Colch) 1993; 85:417-424.
83. Wilkes BM, Susin M, Mento PF. Localization of endothelin-1-like immunoreactivity in human placenta. J Histochem Cytochem 1993; 41:535-541.
84. Genbacev O, Joslin R, Damsky CH, et al. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996; 97:540-550.
85. Wiebke JL, Montrose-Rafizadeh C, Zeitlin PL, et al. of hypoxia on endothelin-1 production by pulmonary vascular endothelial cells. Biochim Biophys Acta 1992; 1134:105-111.
86. Chesley LC. Hypertensive disorders in pregnancy. Appleton-Century-Crofts, New York, 1978:777-822.
87. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: Possible single gene control of preeclampsia and eclampsia and the descendants of eclamptic women. Br J Obstet Gynecol 1986; 93:898-908.
88. Thornton JG, Onwude JL. Pre-eclampsia: discordance among identical twins. BMJ 1991; 303:1241-1242.
89. Hayward C, Livingstone J, Holloway S, et al. An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. Am J Hum 1992; 50:749-757.
90. Cooper DW, Brennecke SP, Wilton AN. Genetics of pre-eclampsia. Hypertens Pregnancy. 1993; 12:1-23.
91. Ward K, Hata A, Jeunemaitre X, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4:59-61.
92. Arngrimsson R, Bjornsson S, Geirsson RT, et al. Genetic and familial predisposition to eclampsia and pre-eclanipsia in a defined population. Br J Obstet Gynaecol 1990; 97:762-769.
93. Redman CWG. Immunology of preeclampsia. Semin Perinatol 1991; 15:257-262.
94. Ober C. The maternal-fetal relationship in human pregnancy: An immunogenetic perspective. Exp Clin Immunol 1992; 9:1-14.
95. Kilpatrick DC, Gibson F, Livingston J, et al. Pre-eclampsia is associated with HLA-DR4 sharing between mother and fetus. Tissue Antigens 1990; 35:178-181.
96. Schneider K, Knutson F, Tamsen L, et al. HLA antigen sharing in preeclampsia. Gynecol Obstet Invest 1994; 37:87-90.
97. Peterson RD, Tuck-Muller CM, Spinnato JA, et al. An HLA-haplotype associated with preeclampsia and intrauterine growth retardation. Am J Reprod Immunol 1994; 31:177-179.
98. Chen G, Wilson R, Wang SH, et al. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104:154-159.
99. Sullivan CA, Magann EF, Perry KG, et al. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 1994; 171:940-943.